[Interview] A New Way To Work With Data In Life Sciences

Founded by renowned database researcher, Turing Award laureate MIT Professor Michael Stonebraker, Paradigm4 is not just any data analytics company …

Continue ›››

[Interview] Expediting Drug Discovery Through Advanced Machine Learning

The application of next-generation data analytics tools, powered by machine learning and artificial intelligence (AI) components, has become a long-term …

Continue ›››

Clinical Research, Artificial Intelligence, and COVID-19

How life sciences companies are reimagining trials during the biggest health crisis in a century Whatever the world was like …

Continue ›››

Top Healthcare Mobile Apps to Explore in 2020

In the "data age," an estimated 81% of Americans own at least one smartphone. That might lead one to wonder …

Continue ›››

FREE WEBINAR: "Why 'Next Best Action' is not enough"

How to create empowering, trusted AI systems for pharma field teams FREE WEBINAR | Tuesday 15th September As an ambitious … Read more ›››

2nd Annual SmartLabs & Laboratory Informatics Congress: Virtual

Oxford Global are proud to announce the SmartLabs & Laboratory Informatics Congress as part of our annual PharmaTec Series: Virtual. … Read more ›››

18th Annual Pharma IT & Data Congress: Virtual

Oxford Global are proud to announce the PharmaIT & Data Congress as part of our annual PharmaTec Series: Virtual. This … Read more ›››

4th Annual Artificial Intelligence in Drug Development: Virtual

Oxford Global are proud to announce the AI in Drug Development Congress as part of our annual PharmaTec Series: Virtual. … Read more ›››

A Leader in COVID-19 Vaccine Race, and the Bright Future for mRNA

Recently my favorite website ENDPOINTSNEWS published a rating of key players in the ongoing COVID-19 vaccine race. Compared to many …

Continue ›››

[Interview] Shaping European AI Regulation To Secure Global Leadership In Healthcare

While the history of Artificial Intelligence (AI) field began in the distant 1950s, its practical value had largely remained limited …

Continue ›››

How To Be Ready For Future Pandemics?

What do antibiotic-resistant bacteria (“superbugs”) and coronaviruses have in common? They both can kill lots of people globally, and they …

Continue ›››

Major VC Rounds For AI-driven Biotechs in 2020

The ongoing COVID19 crisis forced biotech-oriented venture capitalists (VC) to somewhat slow down the pace of their usual deal-flow -- …

Continue ›››